Christopher Haslett

23.8k total citations · 7 hit papers
173 papers, 18.8k citations indexed

About

Christopher Haslett is a scholar working on Immunology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Christopher Haslett has authored 173 papers receiving a total of 18.8k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Immunology, 55 papers in Molecular Biology and 46 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Christopher Haslett's work include Immune Response and Inflammation (52 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (39 papers) and Phagocytosis and Immune Regulation (36 papers). Christopher Haslett is often cited by papers focused on Immune Response and Inflammation (52 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (39 papers) and Phagocytosis and Immune Regulation (36 papers). Christopher Haslett collaborates with scholars based in United Kingdom, United States and Canada. Christopher Haslett's co-authors include Ian Dransfield, Adriano G. Rossi, John Savill, Tariq Sethi, Edwin R. Chilvers, Seamas C. Donnelly, Alison C. MacKinnon, Peter M. Henson, Moira K. B. Whyte and L. Meagher and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Christopher Haslett

173 papers receiving 18.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Resolution of in flammation: state of the art, definitions and terms

2007 862 citations Christopher Haslett, Adriano G. Rossi et al. profile →
Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide.

1985 710 citations Christopher Haslett et al. profile →
Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis

1990 708 citations Ian Dransfield, Christopher Haslett et al. profile →
Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo

1999 620 citations Tariq Sethi, Alison C. MacKinnon et al. profile →
Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators

1993 612 citations Christopher Haslett et al. profile →
Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups

1993 536 citations Seamas C. Donnelly, Christopher Haslett et al. profile →
Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells

1992 508 citations Christopher Haslett, Peter M. Henson et al. The Journal of Immunology profile →

Peers

Countries citing papers authored by Christopher Haslett

Since Specialization

Citations

This map shows the geographic impact of Christopher Haslett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Haslett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Haslett more than expected).

Fields of papers citing papers by Christopher Haslett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Haslett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Haslett. The network helps show where Christopher Haslett may publish in the future.

Co-authorship network of co-authors of Christopher Haslett

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Haslett. A scholar is included among the top collaborators of Christopher Haslett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Haslett. Christopher Haslett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mcl-1 protects eosinophils from apoptosis and exacerbates allergic airway inflammation 2020 ·Thorax ·Jennifer M. Felton, David A. Dorward, Jennifer A. Cartwright, (unknown), Calum T. Robb, Jingang Gui, Ruth W. Craig, Jürgen Schwarze, Christopher Haslett, Rodger Duffin, Ian Dransfield, Christopher D. Lucas, Adriano G. Rossi	10
2	In situ identification of Gram-negative bacteria in human lungs using a topical fluorescent peptide targeting lipid A 2018 ·Science Translational Medicine ·Ahsan R. Akram, Sunay V. Chankeshwara, Emma Scholefield, (unknown), Neil McDonald, Alicia Megía-Fernández, Adam Marshall, Bethany Mills, Nicolaos Avlonitis, Thomas Craven, (unknown), David Collie, Calum Gray, Nik Hirani, Adam T. Hill, John R. W. Govan, Timothy Walsh, Christopher Haslett, Mark Bradley, Kevin Dhaliwal	69
3	A Randomized Controlled Trial of Nebulized Gentamicin in Non–Cystic Fibrosis Bronchiectasis 2010 ·American Journal of Respiratory and Critical Care Medicine ·M Murray, John R. W. Govan, Catherine Doherty, A. John Simpson, Thomas S. Wilkinson, James D. Chalmers, A P Greening, Christopher Haslett, Adam T. Hill	213
4	LONG-TERM NEBULISED GENTAMICIN IN NON-CYSTIC FIBROSIS BRONCHIECTASIS IMPROVES MICROBIAL LOAD, EXERCISE TOLERANCE, EXACERBATION FREQUENCY AND HEALTH-RELATED QUALITY OF LIFE 2009 ·Thorax ·M Murray, J. R. W. Govan, (unknown), A P Greening, Robert D. Gray, John Simpson, Christopher Haslett, Thomas S. Wilkinson, James D. Chalmers, A. T. Hill	2
5	NEUTROPHILS FROM PATIENTS WITH VENTILATOR-ASSOCIATED PNEUMONIA: PRO-INFLAMMATORY AND CYTOTOXIC INTERACTIONS WITH ALVEOLAR EPITHELIUM 2008 ·Thorax ·(unknown), (unknown), Kallirroi Kefala, Tim Wilkinson, Lesley Farrell, Timothy Walsh, (unknown), Jean‐Michel Sallenave, Kevin Dhaliwal, Christopher Haslett, A. John Simpson	1
6	Galectin-3 regulates myofibroblast activation and hepatic fibrosis 2006 ·Proceedings of the National Academy of Sciences ·Neil C. Henderson, Alison C. MacKinnon, Sarah L. Farnworth, Françoise Poirier, Francesco Paolo Russo, John P. Iredale, Christopher Haslett, Kenneth J. Simpson, Tariq Sethi	492
7	Sphingosine Kinase: A Point of Convergence in the Action of Diverse Neutrophil Priming Agents 2002 ·The Journal of Immunology ·Alison C. MacKinnon, (unknown), Edwin R. Chilvers, Adriano G. Rossi, Christopher Haslett, Tariq Sethi	61
8	Prostaglandin D2 and Its Metabolites Induce Caspase-Dependent Granulocyte Apoptosis That Is Mediated Via Inhibition of IκBα Degradation Using a Peroxisome Proliferator-Activated Receptor-γ-Independent Mechanism 2002 ·The Journal of Immunology ·Carol Ward, Ian Dransfield, Joanna Murray, Stuart Farrow, Christopher Haslett, Adriano G. Rossi	107
9	Elevated Levels of Interleukin-8 in Donor Lungs is Associated with Early Graft Failure after Lung Transplantation 2001 ·American Journal of Respiratory and Critical Care Medicine ·Andrew J. Fisher, Seamas C. Donnelly, Nikhil Hirani, Christopher Haslett, Robert M. Strieter, John H. Dark, P. A Corris	198
10	Glucocorticoid Augmentation of Macrophage Capacity for Phagocytosis of Apoptotic Cells Is Associated with Reduced p130Cas Expression, Loss of Paxillin/pyk2 Phosphorylation, and High Levels of Active Rac 2001 ·The Journal of Immunology ·(unknown), Katherine Ross, Adriano G. Rossi, Neil A. Hotchin, Christopher Haslett, Ian Dransfield	131
11	Secretory leukocyte proteinase inhibitor is preferentially increased in patients with acute respiratory distress syndrome 1999 ·European Respiratory Journal ·Jean‐Michel Sallenave, (unknown), (unknown), (unknown), (unknown), Christopher Haslett	39
12	Initial Serum Ferritin Levels in Patients with Multiple Trauma and the Subsequent Development of Acute Respiratory Distress Syndrome 1999 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), Seamas C. Donnelly, (unknown), (unknown), Christopher Haslett, John E. Repine	50
13	Granulocyte Apoptosis and Its Role in the Resolution and Control of Lung Inflammation 1999 ·American Journal of Respiratory and Critical Care Medicine ·Christopher Haslett	422
14	Pulmonary Fibrosis Correlates with Duration of Tissue Neutrophil Activation 1998 ·American Journal of Respiratory and Critical Care Medicine ·Hazel A. Jones, John B. Schofield, Thomas Krausz, Alan R. Boobis, Christopher Haslett	92
15	Modulation of Human Endothelial Thrombomodulin by Neutrophils and Their Release Products 1997 ·American Journal of Respiratory and Critical Care Medicine ·Ian MacGregor, (unknown), Seamas C. Donnelly, Christopher Haslett	52
16	Plasma Elastase Levels and the Development of the Adult Respiratory Distress Syndrome 1995 ·American Journal of Respiratory and Critical Care Medicine ·Seamas C. Donnelly, Ian MacGregor, Alireza Zamani, Malcolm Gordon, Colin E. Robertson, D J Steedman, Keith M. Little, Christopher Haslett	124
17	In Vivo Measurement of Neutrophil Activity in Experimental Lung Inflammation 1994 ·American Journal of Respiratory and Critical Care Medicine ·H. A. Jones, Rachel Clark, C. G. Rhodes, John B. Schofield, Thomas Krausz, Christopher Haslett	166
18	Interaction between Chemoattractants and Bacterial Lipopolysaccharide in the Induction and Enhancement of Neutrophil Adhesion 1990 ·American Journal of Respiratory Cell and Molecular Biology ·Scott K. Young, G. Scott Worthen, Christopher Haslett, Marcia G. Tonnesen, Peter M. Henson	22
19	A Study of the Longer Term Efficacy of Fenfluramine 1983 ·International Journal of Obesity ·(unknown), (unknown), (unknown), Ian H. Frazer, Christopher Haslett, (unknown), (unknown)	1
20	Inappropriate antidiuretic hormone secretion associated with neurohypophyseal choristoma. 1978 ·BMJ ·Christopher Haslett, (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact